N1106 (VX-745) ORAL NANOCRYSTAL CAPSULES (125MG)

RETATRUTIDE

RETATRUTIDE

5-Bromo-3-fluoro-2-methoxypyridine

C6H5BrFNO

AVATROMBOPAG MALEATE [ROUTE CODE AAV]

1-(tert-Butyl) 4-methyl tetrahydro-1,4(2H)-pyridinedicarboxylate

C12H21NO4

Boron zinc oxide (B6Zn2O11), hydrate (2:15)

B2H30O17Zn2

DIPYRIDAMOLE USP

ENCAPSULATION PROCESS AS PERFORMED AT PHOENIXVILLE, PA

TRAVOPROST

MANNITOL, SPRAY DRIED

DE-310 DRUG SUBSTANCE

DIMETHYLDIOCTADECYLAMMONIUM BROMIDE

L-CARNITINE DIR

ALVEOLIT TA S WHITE

FK 788 DRUG SUBSTANCE

2-HYDROXYMETHY1-4-(3-METHOXYPROPOXY)-3-METHYLPYRIDINE

RAPID BIODEGRADABLE HYDROPHOBIC MATERIAL RBHM

ALVEOLIT TA

METHOCARBAMOL

MODIFIED IS-CHO

DEFERIPRONE

LOVASTATIN USP

PAROXETINE HYDROCHLORIDE

TAPORFIN SODIUM DRUG SUBSTANCE

GLUCOSAPURE (GLUCOSAMINE SULFATE)

TERAZOSIN HCL. 2H2O

LOVASTATIN, NON-STERILE BULK, USP

CS-505 DRUG SUBSTANCE

CLIMARA PRO(R) ESTRADIOL/LEVONORGESTREL TRANSDERMAL DELIVERY SYSTEM

FLUDARABINE PHOSPHATE

BINIMETINIB [ROUTE CODE BTQ]